Welcome to our dedicated page for Burcon Nutrascience news (Ticker: BRCNF), a resource for investors and traders seeking the latest updates and insights on Burcon Nutrascience stock.
Burcon NutraScience Corporation (OTCQB: BRCNF; TSX: BU) regularly issues news updates that focus on its progress in plant-based protein innovation and commercialization. As a company that describes itself as a global technology leader in high-performance plant-based proteins for the food and beverage industry, its announcements often highlight developments in product performance, customer adoption, and financing activities.
News items from Burcon frequently cover milestones in commercial production and sales of its branded ingredients, such as Puratein® C canola protein, FavaPro™ fava protein, Peazazz® C pea protein, and Solatein™ sunflower protein. The company reports on first commercial production runs, initial commercial sales, and commercial sales orders for its next generation proteins, as well as the progression of customers from evaluation to purchase orders across its pea, canola, and fava platforms.
Burcon’s releases also include updates on scientific and technical validation of its ingredients. For example, the company has reported on a University of Guelph study in which its pea and sunflower proteins were found to outperform a competitor’s pea protein in a plant-based cheese application, with commentary on melt, stretch, and sensory attributes.
In addition, the company’s news flow features financial and corporate developments, including fiscal results, revenue trends from protein sales and contract manufacturing services, non-brokered private placements of convertible debentures, short-term loan agreements, and insider participation in financings. Governance-related announcements, such as board appointments and shareholder meeting results, are also part of its disclosures.
Investors and industry observers who follow Burcon’s news can track how the company describes its commercialization progress, customer pipeline, manufacturing partnerships, and capital structure as it advances its plant-based protein business.
Burcon NutraScience (TSX: BU, OTCQB: BRCNF) has successfully completed its first contract research project, opening a new revenue stream. The company, known for its plant-based proteins, aims to leverage its expertise in future projects, with several discussions already underway. Burcon's Winnipeg Technical Centre, equipped with advanced commercial processing tools, enables comprehensive food process development, validation, and scale-up. CEO Kip Underwood and SVP Randy Willardsen highlight the strategic alignment and complementary nature of these services with Burcon's core business.
Burcon NutraScience (TSX: BU, OTCQB: BRCNF) will host a conference call and webcast on June 26, 2024, at 5:00 p.m. Eastern to discuss its financial results for the fiscal year ending March 31, 2024. The financial results will be issued via press release beforehand. Investors can access the webcast on Burcon's website under 'Presentations.' The webcast will be archived for future playback. Dial-in details for the live call are provided, including toll-free and international numbers, and a conference ID.
Burcon NutraScience has announced the launch of its high-purity, nutritionally complete canola protein. Derived from non-GMO, Canadian-grown canola seeds, this protein isolate contains all nine essential amino acids with a PDCAAS of 1 and over 90% protein purity. It offers a neutral flavor, high solubility, superior foaming, and exceptional functionality, making it suitable for various food and beverage products.
Burcon plans to begin commercial production and sales in the latter half of this year. The product has received positive feedback from prospective customers. Burcon has also converted its exclusive license with Merit Functional Foods to a non-exclusive one, allowing it to market and sell its canola protein more broadly.
Burcon NutraScience has announced that its common shares have begun trading on the OTCQB Venture Market under the symbol BRCNF, effective May 8, 2024. This move aims to enhance accessibility for US investors and support the company’s focus areas for 2024, which include increasing production to meet hempseed protein demand and introducing new plant-based proteins via a capital-light business model. CEO Kip Underwood emphasized that this development provides more investors with the opportunity to participate in Burcon's growth and its path towards profitability through innovation in plant proteins.
Burcon NutraScience and HPS Food and Ingredients Inc. have achieved the first commercial sales of the world's first hemp protein isolate. This milestone marks a significant partnership in the rapidly growing market for plant-based proteins. Burcon's capital-light approach has allowed them to establish a route-to-market for their high purity hemp protein, enabling speed and influence over production. The company is ramping up production to meet increasing demand, with consumer product launches expected later in 2024.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.